Wiener Doris, Doerge Daniel R, Fang Jia-Long, Upadhyaya Pramod, Lazarus Philip
Cancer Epidemiology and Prevention Program, H. Lee Moffitt Cancer Center, Department of Interdisciplinary Oncology, University of South Florida, Tampa, USA.
Drug Metab Dispos. 2004 Jan;32(1):72-9. doi: 10.1124/dmd.32.1.72.
The nicotine-derived tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), is one of the most potent and abundant procarcinogens found in tobacco and tobacco smoke and is considered to be a causative agent for several tobacco-related cancers. Glucuronidation of the major metabolite of NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), has been implicated as an important mechanism for NNK detoxification. To characterize NNAL metabolism by N-glucuronidation in humans, high-pressure liquid chromatography was used to detect glucuronide conjugates of NNAL formed in human liver microsomes in vitro. In addition to peaks corresponding to the O-glucuronides of NNAL (NNAL-O-Gluc), a second series of peaks were observed in human liver microsomes that were identified by liquid chromatography-mass spectrometry to be NNAL N-glucuronides (NNAL-N-Gluc). Microsomes prepared from liver specimens from individual subjects (n = 42) exhibited substantial variability in the levels of NNAL-N-Gluc (49-fold variability) and NNAL-O-Gluc (49-fold variability) formed in vitro. This variability was likely not due to differences in tissue quality, as substantial variability (5-fold) was also observed in the ratio of NNAL-N-Gluc/NNAL-O-Gluc formation, with a mean ratio of 1.7 in the 42 specimens. Liver microsomes from smokers (n = 14) exhibited no significant difference in the levels of either NNAL-N-Gluc or NNAL-O-Gluc formation, or in the ratio of NNAL-N-Gluc/NNAL-O-Gluc formation, as compared with liver microsomes from never smokers (n = 28). Overexpressed UDP-glucuronosyltransferase (UGT) 1A4 exhibited significant levels of N-glucuronidating activity (V(max)/K(m) = 3.11 microl. min(-1). g(-1)) in vitro; no NNAL-N-glucuronide formation was detected for the 11 other overexpressed UGT enzymes tested in these studies. These results demonstrate the importance of N-glucuronidation in the metabolism of NNAL and the role of UGT1A4 in this pathway.
尼古丁衍生的烟草特有亚硝胺,4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁酮(NNK),是烟草和烟草烟雾中发现的最具活性且含量丰富的前致癌物之一,被认为是多种烟草相关癌症的致病因素。NNK的主要代谢产物4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁醇(NNAL)的葡萄糖醛酸化被认为是NNK解毒的重要机制。为了通过N-葡萄糖醛酸化来表征人类体内NNAL的代谢情况,采用高压液相色谱法检测体外人肝微粒体中形成的NNAL葡萄糖醛酸结合物。除了与NNAL的O-葡萄糖醛酸苷(NNAL-O-Gluc)相对应的峰外,在人肝微粒体中还观察到第二组峰,通过液相色谱-质谱法鉴定为NNAL的N-葡萄糖醛酸苷(NNAL-N-Gluc)。从个体受试者(n = 42)的肝脏标本制备的微粒体在体外形成的NNAL-N-Gluc(49倍变异)和NNAL-O-Gluc(49倍变异)水平上表现出显著差异。这种差异可能不是由于组织质量的差异,因为在NNAL-N-Gluc/NNAL-O-Gluc形成的比率中也观察到显著差异(5倍),42个标本的平均比率为1.7。与从不吸烟者(n = 28)的肝微粒体相比,吸烟者(n = 14)的肝微粒体在NNAL-N-Gluc或NNAL-O-Gluc形成水平上,或在NNAL-N-Gluc/NNAL-O-Gluc形成比率上均无显著差异。过表达的尿苷二磷酸葡萄糖醛酸基转移酶(UGT)1A4在体外表现出显著水平的N-葡萄糖醛酸化活性(V(max)/K(m) = 3.11 μl·min(-1)·g(-1));在这些研究中测试的其他11种过表达的UGT酶未检测到NNAL-N-葡萄糖醛酸苷的形成。这些结果证明了N-葡萄糖醛酸化在NNAL代谢中的重要性以及UGT1A4在该途径中的作用。